In September 2006, the Analytical Proteomics Team from Purdue and Indiana universities was selected by the National Cancer Institute (NCI) as one of five national centers to assess cancer biomarker proteomics technologies. The APT, along with Broad Institute of MIT and Harvard, University of California at San Francisco Lawrence Berkeley National Laboratory, Memorial Sloan-Kettering Cancer Center, and Vanderbilt University School of Medicine formed the Clinical Proteomics Technology Assessment for Cancer (CPTAC) network. Read more